Skip to content

Study on the Analgesic Effect of EEG-Guided Personalized Transcranial Alternating Current Stimulation

Study on the Analgesic Effect of EEG-Guided Personalized Transcranial Alternating Current Stimulation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600126668
Enrollment
Unknown
Registered
2026-06-13
Start date
2026-06-20
Completion date
Unknown
Last updated
2026-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Capsaicin-induced acute experimental pain in healthy subjects

Interventions

Experimental group:The study includes four stimulation conditions: group-target stimulation, individualized single-target stimulation, individualized dual-target stimulation, and sham stimulation. In

Sponsors

School of Life Science and Technology, Xidian University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: Aged 18–40 years, right-handed, physically healthy, without obvious somatic diseases, and able to understand the study procedures and provide written informed consent.

Exclusion criteria

Exclusion criteria: 1. Individuals with severe somatic diseases, neurological disorders, or psychiatric disorders; 2. Individuals with a history of central nervous system diseases, such as epilepsy, traumatic brain injury, or brain tumors; 3. Individuals with chronic or persistent pain symptoms; 4. Individuals who have taken medications within the past month that may affect nervous system function or pain perception; 5. Individuals with alcohol abuse or drug use behaviors; 6. Pregnant or breastfeeding women; 7. Individuals unsuitable for MRI examination, such as those with metallic implants, cardiac pacemakers, or claustrophobia; 8. Individuals with scalp lesions or allergies to electrode materials; 9. Individuals allergic to capsaicin or similar topical irritants, or with skin damage, inflammation, or infection at the experimental site; 10. Individuals with contraindications to magnetic resonance imaging; 11. Individuals with severe sleep disorders or circadian rhythm disturbances, which may affect the stability of EEG signals; 12. Individuals with dependence on psychoactive substances or caffeine, or with abnormal recent intake; 13. Individuals unable to remain at rest during the experiment or with poor compliance.

Design outcomes

Primary

MeasureTime frame
Pain intensity (NRS score);

Secondary

MeasureTime frame
EEG signal;Adverse Events;

Countries

China

Contacts

Public ContactLiu Jixin

School of Life Science and Technology, Xidian University

qfqedu@163.com+86 183 6649 1387

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 21, 2026